Eagle's Eye View: Your Weekly CV Update From ACC.org

In this week's View, Dr. Eagle looks at the difference between quantitative coronary angiography versus intervascular ultrasound to guide PCI. He then discusses paclitaxel-coated balloon catheters vs uncoated balloon angioplasty for treating coronary in-stent restenosis. Finally, Dr. Eagle discusses four studies comparing percutaneous coronary intervention versus coronary artery bypass grafting in patients with left main disease with or without diabetes. Subscribe to Eagle's Eye View

This podcast delves into blood pressure parameters predicting peripheral arterial disease (PAD), five-year outcomes of leadless pacemakers, and the role of palliative care in heart failure treatment. Insights include analyzing ankle blood pressure indices, challenges in palliative care, and upcoming clinical trials in heart failure management.

This week, Dr. Eagle dedicates this episode of Eagle's Eye View to JACC and the upcoming special issue of the Journal edited by Dr. Fuster. Dr. Eagle comments cover JACC articles on lipoprotein(a) and major adverse cardiovascular events in patients with or without baseline atherosclerotic cardiovascular disease, then explores intraoperative anemia and how it mediates sex disparity in operative mortality after coronary artery bypass grafting. Finally, Dr. Eagle talks about the value of surveillance stress testing after percutaneous intervention for patients with multivessel or left main coronary disease. Subscribe to Eagle's Eye View

In this week's View, Dr. Eagle covers coronary calcium scores and how they predict ASCVD risk in the presence of left main disease and diabetes. He then explores TRI-SCORE and the benefits of intervention in patients with severe tricuspid regurgitation. Finally, Dr. Eagle talks about booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults. Subscribe to Eagle's Eye View

In this week's View, Dr. Eagle covers opportunities in the postpartum period to reduce cardiovascular disease risk after adverse pregnancy outcomes. He then explores the apparent increased risk of myocardial infarction, heart failure and atrial fibrillation after spinal cord injury. Finally, Dr. Eagle talks about a systematic review and network meta-analysis of coronary angiography, intravascular ultrasound, and optical coherence tomography in the guidance of percutaneous coronary intervention. Subscribe to Eagle's Eye View

In this week's View, Dr. Eagle discusses the development and validation of the American Heart Association's PREVENT risk assessment tool. He then explores implantable hemodynamic monitors and their role in improving survival in patients with heart failure and reduced ejection fraction. Finally, Dr. Eagle talks about the 10-year outcomes of the NOTION trial regarding transcatheter or surgical aortic valve implantation. Subscribe to Eagle's Eye View

In this week's View, Dr. Eagle discusses recovery in peripartum cardiomyopathy. He then explores a systematic review and meta-analysis of the association of physical activity and cognitive decline among older adults. Finally, Dr. Eagle talks about the promises and perils of consumer mobile technologies in cardiovascular care. Subscribe to Eagle's Eye View

In this week's View, Dr. Eagle discusses the use of non–Vitamin-K antagonist oral anticoagulants versus warfarin across the spectrum of body mass index and weight. He then explores sex disparities in longitudinal use and intensification of guideline-directed medical therapy among patients with newly diagnosed heart failure with reduced ejection fraction. Finally, Dr. Eagle talks about polygenic risk in families with spontaneous coronary artery dissection. Subscribe to Eagle's Eye View

In this week's View, Dr. Eagle discusses a JACC State of the Art Review noting direct oral anticoagulants (DOACs) should not be standard treatment. He then explores various ways of guiding intervention for complex coronary lesions by optical coherence tomography (OCT) or intravascular ultrasound (IVUS). Finally, Dr. Eagle talks about a prespecified analysis of the CLEAR Outcomes Randomized Trial on the impact of bempedoic acid on total cardiovascular events. Subscribe to Eagle's Eye View